DaVinci touts results from spinal cord trial

Following up on eight acute and chronic spinal cord injury patients who were injected with bone marrow stem cells two years ago, researchers say that the therapy proved safe and effective in improving their quality of life. DaVinci Biosciences undertook the study in Ecuador and has now issued a follow-up report claiming that MRIs have revealed "noticeable morphological changes within the spinal cord after administration of autologous bone marrow derived stem cells." There was no tumor formation, increased pain or deterioration of function following administration of the stem cell treatment, reports DaVinci. DaVinci report

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.